drugset / Trial / NCT06361277
To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers
RandomizedSequentialOpen-labelOther
Summary
The objective is to evaluate the safety and pharmacokinetic characteristics after co-administration of JW0202 and C2202 and co-administration of C2205 and JW0201 in healthy volunteers under fasting conditions
Timeline
- Start
- 2023-11-03
- Primary completion
- 2023-11-20
- Completion
- 2023-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C2202 | Unknown | — | Oral |
| Subject | C2205 | Unknown | — | Oral |
| Subject | JW0201 | Unknown | — | Oral |
| Subject | JW0202 | Unknown | — | Oral |
Indications
No indication recorded.